This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ . Cancer Statistics 2007. CA J Clin 2007; 57: 43–66.
Boyle P, Ferlay J . Cancer incidence and mortality in Europe 2004. Ann Oncol 2005; 16: 481–488.
Durie BGM, Kyle R, Belch A, Bensinger W, Blade J, Boccadoro M et al. Myeloma management guidelines: A consensus report from the scientific advisors of the international myeloma foundation. Hematol J 2003; 4: 379–398.
Durie BGM . New approaches to treatment for multiple myeloma: durable remission and quality of life as primary goals. Clin Lymphoma Myeloma 2005; 6: 181–190.
Dudeney S, Lieberman IH, Reinhardt MK, Hussein M . Kyphoplasty in the treatment of osteolytic vertebral compression fractures as a result of multiple myeloma. J Clin Oncol 2002; 20: 2382–2387.
Pflugmacher R, Beth P, Schroeder RJ, Schaser KD, Melcher I . Balloon kyphoplasty for the treatment of pathological fractures in the thoracic and lumbar spine caused by metastasis: one year follow-up. Acta Radiol 2007; 48: 89–95.
Pflugmacher R, Kandziora F, Schroeder RJ, Melcher I, Haas NP, Klostermann CK et al. Percutaneous balloon Kyphoplasty in the treatment of pathological vertebral body fracture and deformity in multiple myeloma: a one-year follow-up. Acta Radiol 2006; 47: 369–376.
Khanna AJ, Reinhardt MK, Togawa D, Lieberman IH . Functional outcomes of Kyphoplasty for the treatment of osteoporotic and osteolytic vertebral compression fractures. Osteoporos Int 2006; 17: 817–826.
Gerszten PC, Welch WC . Combined percutaneous transpedicular tumor debulking and Kyphoplasty for pathological compression fractures. Technical note. J Neurosurg Spine 2007; 6: 92–95.
Atalay B, Caner H, Gokce C, Altinors N . Kyphoplasty: two years of experience in a neurosurgery department. Surg Neurol 2005; 64 (S2): 72–76.
Crandall D, Slaughter D, Hankins PJ, Moore C, Jerman J . Acute versus chronic vertebral compression fractures treated with kyphoplasty: early results. Spine J 2004; 4: 418–424.
Fourney DR, Schomer DF, Nader R, Chlan-Fourney J, Siki D, Ahrar K et al. Percutaneous vertebroplasty and kyphoplasty for painful vertebral body fractures in cancer patients. J Neurosurg 2003; 98 (1 suppl): 21–30.
Gaitanis IA, Hadjipavlou AG, Katonis PG, Tzermiadianos MN, Pasku DS, Datwardhan AG et al. Balloon kyphoplasty for the treatment of pathological vertebral compression fractures. Eur Spine J 2005; 14: 250–260.
Gerszten PC, Germanwala A, Burton SA, Welch WC, Ozhasoglu C, Vogel WJ . Combination of kyphoplasty and spinal radiotherapy: a new treatment paradigm for pathological fractures. Neurosurg Focus 2005; 18: e8.
Hentschel SJ, Burton AW, Fourney DR, Rhines LD, Mendel E . Percutaneous vertebroplasty and kyphoplasty performed at a cancer center: refuting proposed contraindications. J Neurosurg Spine 2005; 2: 440–446.
Kose KC, Cebesoy O, Akan B, Altinel L, Dincer D, Yazar T . Functional results of vertebral augmentation technique in pathological vertebral fractures of myelomatous patients. J Natl Med Assoc 2006; 98: 1543–1548.
Lane JM, Hong R, Koob J, Kiechle T, Niesvizky R, Pearse R et al. Kyphoplasty enhances function and structural alignment in multiple myeloma. Clin Orthop 2004; 426: 49–53.
Ledlie JT, Renfro MB . Kyphoplasty treatment of vertebral body compression fractures: 2-year outcomes show sustained benefits. Spine 2006; 31: 57–64.
Lieberman I, Reinhardt MK . Vertebroplasty and kyphoplasty for osteolytic vertebral collapse. Clin Orthop 2003; 415S: S176–S186.
Weber CH, Krotz M, Hoffmann RT, Euler E, Heining S, Pfeifer KJ et al. CT-guided vertebroplasty and kyphoplasty: comparing technical success rate and complications in 101 cases. Rofo 2006; 278: 610–617. (Article in German, abstract in English).
Vrionis FD, Hamm A, Stanton N, Sullivan M, Obadia M, Muiguel R . Kyphoplasty for tumor-associated spinal fractures. Tech Reg Anesth Pain Manag 2005; 9: 35–39.
Eck JC, Nachtigall D, Humphreys SC, Hodges SD . Comparison of vertebroplasty and balloon kyphoplasty for treatment of vertebral compression fractures: a meta-analysis of the literature. The Spine Journal 2007, 1–10.
Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR . Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1999; 159: 1215–1220.
Author information
Authors and Affiliations
Consortia
Corresponding authors
Appendix
Appendix
International Myeloma Working Group:
Ray Alexanian, MD Anderson, Houston, Texas, USA
Kenneth Anderson, DFCI, Boston, Massachusetts, USA
Michael Attal, Purpan Hospital, Toulouse, France
Herve Avet-Loiseau, Institute de Biologie, Nantes, France
Ashraf Badros, University of Maryland, Baltimore, Maryland, USA
Leif Bergsagel, Mayo Clinic Scottsdale, Scottsdale, Arizona, USA
Joan Bladé, Hospital Clinica, Barcelona, Spain
Bart Barlogie, MIRT UAMS Little Rock, Arkanas, USA
Regis Batille, Institute de Biologie, Nantes, France
Meral Beksac, Ankara University, Ankara, Turkey
Andrew Belch, Cross Cancer Institute, Alberta, Canada
Bill Bensinger, Fred Hutchinson Cancer Center, Seattle, Washington, USA
Mario Boccadoro, University of Torino, Torino, Italy
Michele Cavo, Universita di Bologna, Bologna, Italy
Wen Ming Chen, MM Research Center of Beijing, Beijing, China
Tony Child, Leeds General Hospital, Leeds, United Kingdom
James Chim, Department of Medicine, Queen Mary Hospital, Hong Kong
Ray Comenzo, Memorial Sloane-Kettering, New York City, New York, USA
John Crowley, Cancer Research and Biostatistics, Seattle, Washington, USA
William Dalton, H Lee Moffitt, Tampa, Florida, USA
Faith Davies, Royal Marsden Hospital, London, England
Cármino de Souza, Univeridade de Campinas, Caminas, Brazil
Michel Delforge, University Hospital Gasthuisberg, Leuven, Belgium
Meletios Dimipoulous, Alexandra Hospital, Athens, Greece
Angela Dispenzieri, Mayo Clinic, Rochester, Minnesota, USA
Hermann Einsele, Universitätsklinik Würzburg, Würzburg, Germany
Theirry Facon, Centre Hospitalier Regional Universitaire de Lille, Lille, France
Dorotea Fantl, Socieded Argentinade Hematolgia, Buenos Aires, Argentina
Jean-Paul Fermand, Hopitaux de Paris, Paris, France
Rafael Fonseca, Mayo Clinic Scottsdale, Scottsdale, Arizona, USA
Gosta Gahrton, Karolinska Institute for Medicine, Huddinge, Sweden
Morie Gertz, Mayo Clinic, Rochester, Minnesota, USA
John Gibson, Royal Prince Alfred Hospital, Sydney, Australia
Hartmut Goldschmidt, University Hospital Heidelberg, Heidelberg, Germany
Philip Greipp, Mayo Clinic, Rochester, Minnesota, USA
Roman Hajek, Brno University, Brno, Czech Republic
Izhar Hardan, Tel Aviv University, Tel Aviv, Israel
Jean-Luc Harousseau, Institute de Biologie, Nantes, France
Hiroyuki Hata, Kumamoto University Hospital, Kumamoto, Japan
Yutaka Hattori, Keio University School of Medicine, Tokyo, Japan
Joy Ho, Royal Prince Alfred Hospital, Sydney, Australia
Vania Hungria, Clinica San Germano, Sao Paolo, Brazil
Mohamad Hussein, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA
Shinsuke Ida, Nagoya City University Medical School, Nagoya, Japan
Peter Jacobs, Constantiaberg Medi-Clinic, Plumstead, South Africa
Sundar Jagannath, St Vincent's Comprehensive Cancer Center, New York, New York, USA
Hou Jian, Shanghai Chang Zheng Hospital, Shanghai, China
Douglas Joshua, Royal Prince Alfred Hospital, Sydney, Australia
Michio Kawano, Yamaguchi University, Ube, Japan
Shaji Kumar, Department of Hematology, Mayo Clinic, Minnesota, USA
Robert Kyle, Department of Laboratory Med. and Pathology, Mayo Clinic, Minnesota, USA
Juan Lahuerta, Grupo Espanol di Mieloma, Hospital Universitario, Madrid, Spain
Jae Hoon Lee, Gachon University Gil Hospital, Incheon, Korea
Henk Lokhorst, University Medical CenterUtrecht, Utrecht, The Netherlands
Heinz Ludwig, Wilhelminenspital Der Stat Wien, Vienna, Austria
Xavier LeLeu, Hospital Huriez, CHRU Lille, France
Angelo Maiolino, Rua fonte da Saudade, Rio de Janeiro, Brazil
Jayesh Mehta, Northwestern University, Chicago, Illinois, USA
GianPaolo Merlini, University of Pavia, Pavia, Italy
Philippe Moreau, University Hospital, Nantes, France
Gareth Morgan, Royal Marsden Hospital, London, England
Nikhil Munshi, Diane Farber Cancer Institute, Boston, Massachusetts, USA
Antonio Palumbo, Cathedra Ematologia, Torino, Italy
Santiago Pavlovsky, Fundaleu, Buenos Aires, Argentina
Ruben Niesvizky, Weill Medical College of Cornell University, New York, New York, USA
Yana Novis, Hospital SírioLibanês, Bela Vista, Brazil
Amara Nouel, Hospital Rutz y Paez, Bolivar, Venezuela
Raymond Powles, Leukaemia & Myeloma, Wimbledon, England
Linda Pilarski, University of Alberta, Alberta, Canada
S Vincent Rajkumar, Mayo Clinic, Rochester, Minnesota, USA
Donna Reece, Princess Margaret, Toronto, Canada
Tony Reiman, Cross Cancer Institute, Alberta, Canada
Paul Richardson, Dana Farber Cancer Institute, Boston, Massachusetts, USA
Angelina Rodriquez Morales, Bonco Metro Politano de Sangre, Caracas, Venezuela
Orhan Sezer, Department of Hem/Onc, Universitatsklinikum Charite, Berlin, Germany
John Shaughnessy, M.I.R.T. UAMS, Little Rock, Arkansas, USA
Kazayuki Shimizu, Nagoya City Midori General Hospital, Nagoya, Japan
David Siegel, Hackensack, Cancer Center, Hackensack, New Jersey, USA
Guido Tricot, M.I.R.T. UAMS, Little Rock, Arkansas, USA
Jesus San Miguel, University of Salamanca, Salamanca, Spain
Seema Singhal, Northwestern University, Chicago, Illinois, USA
Pieter Sonneveld, Erasmus MC, Rotterdam, The Netherlands
Chaim Shustik, McGill, Toronto, Canada
Andrew Spencer, The Alfred Hospital, Melbourne, Australia
Keith Stewart, Mayo Clinic Scottsdale, Scottsdale, Arizona, USA
Patrizia Tosi, Italian Cooperative Group, Istituto di Ematologia Seragnoli, Bologna, Italy
Ingemar Turesson, Department of Hematology, Malmo University, Malmo, Sweden
Brian Van Ness, University of Minnesota, Minneapolis, Minnesota, USA
Ivan Van Riet, Brussels Vrija University, Brussels, Belgium
Robert Vescio, Cedars-Sinai Outpatient Cancer Center, Los Angeles, California, USA
David Vesole, St Vincent's Comprehensive Cancer Center, New York, New York, USA
Anders Waage, University Hospital, Trondheim, Norway NSMG
Michael Wang, M.D. Anderson, Houston, Texas, USA
Donna Weber, MD Anderson, Houston, Texas, USA
Jan Westin, University of Lund, Lund, Sweden
Keith Wheatley, University of Birmingham, Birmingham, United Kingdom
Dina B Yehuda, Department of Hematology, Hadassah University Hospital, Hadassah, Israel
Jeffrey Zonder, SWOG, Department of Hem/Onc., Karmanos Cancer Institute, Michigan, USA
Rights and permissions
About this article
Cite this article
Hussein, M., Vrionis, F., Allison, R. et al. The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement. Leukemia 22, 1479–1484 (2008). https://doi.org/10.1038/leu.2008.127
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2008.127
This article is cited by
-
In vivo antitumor efficacy of 17-AAG loaded PMMA in a human multiple myeloma xenograft mouse model
Clinical and Experimental Medicine (2022)
-
The role of cement augmentation with percutaneous vertebroplasty and balloon kyphoplasty for the treatment of vertebral compression fractures in multiple myeloma: a consensus statement from the International Myeloma Working Group (IMWG)
Blood Cancer Journal (2019)
-
Bone marrow washout for multilevel vertebroplasty in multiple myeloma spinal involvement. Technical note.
European Spine Journal (2019)
-
Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma
Clinical Epigenetics (2017)
-
International Myeloma Working Group recommendations for global myeloma care
Leukemia (2014)